Copyright
©The Author(s) 2022.
World J Hepatol. Jun 27, 2022; 14(6): 1162-1172
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1162
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1162
Table 2 Comparison of tumor characteristics and response between patients with viral hepatitis only (group A) and those with viral hepatitis concurrent with alcohol consumption (group B)
Variables | Group A (n = 53), % | Group (n = 16), % | P value |
Multinodular (> 1 lesion) | 44 (83.0) | 14 (87.5) | 1.000 |
Largest tumor size (cm): Median (IQR) | 5.3 (3.7 to 9.0) | 4.3 (2.6 to 9.0) | 0.399 |
Largest tumor sized > 5 cm | 27 (50.9) | 9 (56.2) | 0.710 |
Number of TACE sessions: median (IQR) | 2 (1 to 3) | 2 (1 to 3) | 0.301 |
Achieved complete respond | 13 (24.5) | 0 (0) | 0.030 |
- Citation: Rattanasupar A, Chang A, Prateepchaiboon T, Pungpipattrakul N, Akarapatima K, Songjamrat A, Pakdeejit S, Prachayakul V, Piratvisuth T. Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization . World J Hepatol 2022; 14(6): 1162-1172
- URL: https://www.wjgnet.com/1948-5182/full/v14/i6/1162.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i6.1162